Pirfenidone: A novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 1, 1998, Pages 219-223

  Lee, Byung Seok ^a   Margolin, Solomon B ^b   Nowak, Romana A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Marnac Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; PIRFENIDONE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; TUMOR CELL CULTURE; UTERUS MYOMA;

EID: 0031738215     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.1.4503     Document Type: Article

References (27)

1. Merrill JA, Creasman WT. 1990 Disorders of the uterine corpus. In: Scott JR, DiSaia, Hammond CB, Spellacy WN, eds. Danforth's obstetrics and gynecology. 6th ed. Philadelphia: Lippincott; 1023-1039.
2. Buttram VC, Reiter RC. 1981 Uterine leiomyomata: etiology, symptomatology and management. Fertil Steril. 36:433-445.
3. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. 1994 Hysterectomy in the United States, 1988-1990. Obstet Gynecol. 83:549-555.
4. Farber M, Conrad S, Heinrichs NL, Herrman WL. 1972 Estradiol binding by fibroid tumors and normal myometrium. Obstet Gynecol. 40:479-483.
5. Wilson EA, Yang F, Rees ED. 1980 Estradiol and progesterone binding in uterine leiomyoma and in normal uterine tissues. Obstet Gynecol. 55:20-24.
6. Otubu JA, Buttram VC, Besch NF, Besch PK. 1982 Unconjugated steroids in leiomyomas and tumor-bearing myometrium. Am J Obstet Gynecol. 143:130-133.
7. Lippman ME, Dickson RB, Knabbe C, et al. 1986 Autocrine and paracrine growth regulation of breast cancer. Breast Cancer Res Treat. 7:59-70.
8. Fisher DA, Lakshmanan J. 1990 Metabolism and effects of epidermal growth factor and their related growth factors in mammals. Endocr Rev. 11:418-442.
9. Stewart EA, Friedman AJ. 1992 Steroidal treatment of myomas: preoperative and long term medical therapy. Semin Reprod Endocrinol. 10:344-357.
10. Iyer SN, Wild JS, Schiedt MJ, Hyde DM, Margolin SB, Gin SN. 1995 Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters. J Lab Clin Med. 125:779-785.
11. Shetlar MR, Shetlar CL. 1995 Effect of antifibrosis drug on the survival of keloid transplants in athymic mice. FASEB J 9:A967.
12. Lurton JM, Margolin SB, Raghu G. 1996 Pirfenidone inhibits the stimulatory effects of pro-fibrotic cytokines on human fibroblasts in vitro. Am J Respir Crit Care Med 153:A403.
13. Nowak RA, Rein MS, Heffner LJ, Friedman AJ, Tashjian Jr AH. 1993 Production of prolactin by smooth muscle cells cultured from human uterine fibroid tumors. J Clin Endocrinol Metab. 76:1308-1313.
14. Stewart EA, Friedman AJ, Peck K, Nowak RA. 1994 Relative overexpression of collagen type I and collagen type III mRNAs by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab. 79:900-906.
15. Stewart EA, Floor AE, Jain P, Nowak RA. 1995 Increased expression of messenger RNA for collagen type I, collagen type III, and fibronectin in myometrium of pregnancy. Obstet Gynecol. 86:417-422.
16. Raghu G, Mageto Y, Lurton J, Limond M. 1997 Treatment of idiopathic pulmonary fibrosis (IPF) with a new antifibrotic drug-pirfenidone. Am J Respir Crit Care Med. 155:A741.
17. Tiltman A. 1985 The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol. 4:89-96.
18. Kawaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogake H, Mori T. 1989 Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol. 160:637-641.
19. Rein MS, Nowak RA. 1992 Biology of uterine myomas and myometrium in vitro. Semin Reprod Endocrinol. 10:310-319.
20. Harrison-Woolrych ML, Charnock-Jones DS, Smith SK. 1994 Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyoma using reverse transcriptase polymerase chain reaction. J Clin Endocrinol Metab. 78:1179-1184.
21. Vollenhoven BJ, Herington AC, Hearly DL. 1993 Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab. 76:1106-1110.
22. Rauk PN, Surti U, Roberts JM, Michalopoulos. 1995 Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells. Am J Obstet Gynecol. 173:571-577.
23. Stewart EA, Nowak RA. 1996 Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update. 2:295-306.
24. Arici A, Sozen I, Olive D. 1995 Transforming growth factor beta 3 promotes proliferation of myometrial and leiomyoma cells. J Soc Gynecol Invest. 2:411.
25. Ferenczy A, Richart RM, Okagaki T. 1971 A comparative ultrastructural study of leiomyosarcoma, cellular leiomyoma, and leiomyoma of uterus. Cancer. 28:1004-1018.
26. Kawaguchi K, Fujii S, Konishi I, Okamura H, Mori T. 1985 Ultrastructural study of cultured smooth muscle cells from uterine leiomyoma and myometrium under the influence of sex steroids. Gynecol Oncol. 21:32-41.
27. Fujita M. 1985 Histological and biochemical studies of collagen in human uterine leiomyomas [English abstract]. Hokkaido Igaku Zasshi. 60:602-615.